The company was established in Asia in China. The main office of represented VC is situated in the Shenzhen.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Apps, Human Computer Interaction. Among the most popular portfolio startups of the fund, we may highlight Miracor Medical, 0glass. The fund has exact preference in some founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Ming capital, startups are often financed by SHS Gesellschaft fur Beteiligungsmanagement, Earlybird Venture Capital, Delta Partners. The meaningful sponsors for the fund in investment in the same round are SFPI-FPIM, Meusinvest, SHS Gesellschaft fur Beteiligungsmanagement. In the next rounds fund is usually obtained by Yungpark Lingzhong Fund, SFPI-FPIM, Quest for Growth.
The real fund results show that this VC is 47 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year.
Related Funds
Fund Name | Location |
7cool | China, Jiangsu, Wuxi Shi |
Adour Business Angels | Aquitaine, France, Pau |
Asclepios Biosearch | England, London, United Kingdom |
Atom Ventures | China, Jingan, Shanghai |
Communitech HYPERDRIVE | Canada, Kitchener, Ontario |
Dezheng Touzi | China, Guangdong, Guangzhou |
Guangdong Bobaolon | China, Guangdong Province, Jieyang City |
Horizon Capital | - |
InvestHER Ventures | Chicago, Illinois, United States |
Lionheart Ventures | California, San Francisco, United States |
Matthew Pritzker Company | Chicago, Illinois, United States |
MOHARA | England, London, United Kingdom |
Puhua Jingxin Guzhou Health | - |
Quayle Munro | England, London, United Kingdom |
Shanghai Liuhe Capital | China, Shanghai |
Shengyu Jiatian | Beijing, Beijing, China |
Strattech Partners | Devon, Pennsylvania, United States |
SWAN Venture Fund | Kirkland, United States, Washington |
Utah Angels 2 | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Svision | $46M | 09 Mar 2023 | Huizhou, Guangdong Province, China | ||
Binhui Biotech | $46M | 19 Apr 2022 | Wuhan, Hubei, China | ||
Gene Vector | $3M | 10 Mar 2022 | Chengdu, Sichuan, China | ||
CareTaker Medical | 02 Jun 2020 | Virginia, United States | |||
0glass | $1M | 18 May 2017 | Guangdong Province |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Svision | $46M | 09 Mar 2023 | Huizhou, Guangdong Province, China | ||
Binhui Biotech | $46M | 19 Apr 2022 | Wuhan, Hubei, China | ||
Gene Vector | $3M | 10 Mar 2022 | Chengdu, Sichuan, China | ||
CareTaker Medical | 02 Jun 2020 | Virginia, United States | |||
0glass | $1M | 18 May 2017 | Guangdong Province |